Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Oncology·MeSH: Pancreatic Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| CAN-2409 | Candel Therapeutics, Inc. (CADL) |
Frequently asked questions
How many drugs are in development for Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)?
BioSniper tracks 1 drug in development for Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) across 1 company.
How many clinical trials target Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)?
There are 1 clinical trial targeting Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) tracked by BioSniper.
Deep-dive into Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis